PAOLETTA, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 969
AS - Asia 456
EU - Europa 260
AF - Africa 99
SA - Sud America 81
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 4
Totale 1.877
Nazione #
US - Stati Uniti d'America 919
SG - Singapore 174
CN - Cina 84
VN - Vietnam 57
BR - Brasile 51
IT - Italia 43
HK - Hong Kong 37
DE - Germania 25
FI - Finlandia 21
FR - Francia 19
GB - Regno Unito 15
NL - Olanda 15
UA - Ucraina 14
PL - Polonia 13
IN - India 11
RU - Federazione Russa 11
SE - Svezia 10
AR - Argentina 7
CY - Cipro 7
MX - Messico 7
IE - Irlanda 6
MK - Macedonia 6
PK - Pakistan 6
PY - Paraguay 6
RW - Ruanda 6
SY - Repubblica araba siriana 6
AT - Austria 5
BG - Bulgaria 5
CM - Camerun 5
EE - Estonia 5
IQ - Iraq 5
LA - Repubblica Popolare Democratica del Laos 5
MN - Mongolia 5
AM - Armenia 4
BA - Bosnia-Erzegovina 4
CW - ???statistics.table.value.countryCode.CW??? 4
EG - Egitto 4
GR - Grecia 4
GT - Guatemala 4
IL - Israele 4
KR - Corea 4
LB - Libano 4
MD - Moldavia 4
MG - Madagascar 4
MW - Malawi 4
NE - Niger 4
NG - Nigeria 4
PA - Panama 4
SO - Somalia 4
TN - Tunisia 4
TR - Turchia 4
TZ - Tanzania 4
VC - Saint Vincent e Grenadine 4
AE - Emirati Arabi Uniti 3
BB - Barbados 3
BD - Bangladesh 3
BS - Bahamas 3
BW - Botswana 3
CA - Canada 3
CO - Colombia 3
CU - Cuba 3
DZ - Algeria 3
GH - Ghana 3
GN - Guinea 3
GP - Guadalupe 3
HU - Ungheria 3
ID - Indonesia 3
JM - Giamaica 3
KE - Kenya 3
KH - Cambogia 3
LU - Lussemburgo 3
LV - Lettonia 3
MA - Marocco 3
MZ - Mozambico 3
NO - Norvegia 3
NP - Nepal 3
PS - Palestinian Territory 3
RE - Reunion 3
SD - Sudan 3
VE - Venezuela 3
YT - Mayotte 3
ZW - Zimbabwe 3
AF - Afghanistan, Repubblica islamica di 2
AO - Angola 2
BF - Burkina Faso 2
BO - Bolivia 2
CD - Congo 2
CH - Svizzera 2
CI - Costa d'Avorio 2
CL - Cile 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
ES - Italia 2
ET - Etiopia 2
GA - Gabon 2
GF - Guiana Francese 2
HN - Honduras 2
JO - Giordania 2
JP - Giappone 2
Totale 1.814
Città #
Fairfield 142
Ashburn 91
Singapore 87
Houston 86
Santa Clara 56
Woodbridge 56
Seattle 54
Chandler 48
Cambridge 45
Jacksonville 45
Wilmington 42
Hong Kong 37
Beijing 26
Ann Arbor 21
Boardman 20
Dong Ket 18
Princeton 18
Ho Chi Minh City 17
San Diego 15
Des Moines 10
Roxbury 10
Hanoi 8
Medford 8
Munich 8
Bytom 7
Nanjing 7
Cagliari 6
Helsinki 6
Kigali 6
Skopje 5
Antananarivo 4
Columbus 4
Council Bluffs 4
Dar es Salaam 4
Dublin 4
Florence 4
Guatemala City 4
Haiphong 4
Kingstown 4
Limassol 4
New York 4
Novara 4
Panama City 4
São Paulo 4
Tallinn 4
Ulan Bator 4
Vientiane 4
Warsaw 4
Willemstad 4
Accra 3
Athens 3
Atlanta 3
Belo Horizonte 3
Bridgetown 3
Changsha 3
Chennai 3
Ciudad del Este 3
Conakry 3
Dallas 3
Douala 3
Gaborone 3
Harare 3
Lagos 3
Lahore 3
Lilongwe 3
Los Angeles 3
Moscow 3
Nairobi 3
Nassau 3
Niamey 3
North Bergen 3
Phnom Penh 3
Rio de Janeiro 3
Rome 3
Tel Aviv 3
Turku 3
Vienna 3
Yerevan 3
Abidjan 2
Addis Ababa 2
Amman 2
Annapolis 2
Apia 2
Asunción 2
Belgrade 2
Biên Hòa 2
Borama 2
Bucheon-si 2
Cairo 2
Casablanca 2
Castries 2
Chisinau 2
Cochabamba 2
Contagem 2
Curitiba 2
Dili 2
Dushanbe 2
Ferrara 2
Frankfurt am Main 2
Havana 2
Totale 1.212
Nome #
The Significance of 2-Furyl Ring Substitution with a 2-(para-substituted) Aryl Group in a New Series of Pyrazolo-triazolo-pyrimidines as Potent and Highly Selective hA(3) Adenosine Receptors Antagonists: New Insights into Structure-Affinity Relationship and Receptor-Antagonist Recognition 187
A Novel Generalized 3D-QSAR Model of Camptothecin Analogs 180
Designing adenosine receptors antagonists using an in silico approach 168
Pyrazolo[4,3-: E] [1,2,4]triazolo[1,5-c] pyrimidines to develop functionalized ligands to target adenosine receptors: Fluorescent ligands as an example 162
2-Phenylpyrazolo[4,3-d]pyrimidin-7-one as a New Scaffold To Obtain Potent and Selective Human A(3) Adenosine Receptor Antagonists: New Insights into the Receptor-Antagonist Recognition 158
Revisiting a Receptor-Based Pharmacophore Hypothesis for Human A2AAdenosine Receptor Antagonists 152
Synthesis and pharmacological characterization of a new series of 5,7-disubstituted-[1,2,4]triazolo[1,5-a][1,3,5]triazine derivatives as adenosine receptor antagonists: A preliminary inspection of ligand-receptor recognition process 148
Exploring the Directionality of 5-Substitutions in a New Series of 5-Alkylaminopyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine as a Strategy To Design Novel Human A3Adenosine Receptor Antagonists. 129
Fluorescent ligands for adenosine receptors 125
Discovery of novel A3 adenosine receptor ligands based on chromone scaffold. 125
Novel fluorescent antagonist as a molecular probe in A(3) adenosine receptor binding assays using flow cytometry. 124
Synthesis and pharmacological characterization of a new series of 5,7-disubstituted-[1,2,4]triazolo[1,5-a][1,3,5]triazine derivatives as adenosine receptor antagonists: a preliminary receptor-driven SAR profile 114
The Identification of the 2-Phenylphthalazin-1(2H)-one Scaffold as a New Decorable Core Skeleton for the Design of Potent and Selective Human A(3) Adenosine Receptor Antagonists 107
Totale 1.879
Categoria #
all - tutte 6.430
article - articoli 5.804
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.234


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202191 0 0 0 0 0 13 1 11 20 7 16 23
2021/2022175 7 20 32 6 3 2 9 25 3 7 27 34
2022/2023121 24 2 0 6 28 28 0 9 13 1 8 2
2023/2024116 3 15 17 12 12 12 2 18 4 3 12 6
2024/2025343 0 12 10 20 70 14 11 27 25 19 59 76
2025/2026616 24 87 156 174 157 18 0 0 0 0 0 0
Totale 1.879